Top Life Sciences Startups in 2027

Want to advance the frontiers of understanding? we develop innovative open source software platforms and integrate them into research, processes, and products. cmake, paraview, the visualization toolkit (vtk), and the insight segmentation and registration toolkit (itk) are among the platforms that complement our expertise in computer vision, data and analytics, high-performance computing and visualization, medical computing, and software process management. from meaningful work, to flexible hours, to collaboration, to a hardware budget, to tech lunches, to a clothing stipend, to family outings, there are many reasons to join us and make an impact.

Founded in 2017, dutchie is an all-in-one technology platform powering dispensary operations, while providing consumers with safe and easy access to cannabis. Dutchie aims to further support the positive societal change the cannabis space brings to the world through health and wellness benefits, social justice, and by empowering local communities through tax revenue. Powering thousands of dispensaries across 35+ markets throughout the United States and Canada, dutchie is the leading technology company in the cannabis space and was named to Fast Company’s 10 most innovative companies in North America and LinkedIn’s Top 50 Startups. Dutchie has raised $253M in funding to date, backed by Tiger Global, Dragoneer, DFJ Growth, Thrive Capital, Howard Schultz, Snoop Dogg’s Casa Verde Capital, Gron Ventures, members of the founding team at DoorDash, Kevin Durant’s Thirty Five Ventures, and other notable angel investors.

NimbleRx is building the largest, most convenient pharmacy in the world. NimbleRx is a pharmacy platform that enables prescriptions to be delivered the same day as prescribed to patients. We are a mission driven organization and work closely with leading healthcare institutions including physician offices and hospitals to improve the healthcare experience and outcomes. NimbleRx combines a consumer portal, efficient, automated insurance billing and a deep integration with the existing independent pharmacy infrastructure. Our investors include some of the best venture firms, angels and angel funds in Silicon Valley. Come join us!

At Ophelia, the users we build products for wear as many hats as we do. We build products for our patients to connect with Ophelia and their providers, for our team members to better understand our data, and for our clinicians to provide high quality care to our patients. We’ve built a state of the art, proprietary electronic health record for our team to provide tailored treatment to each of their patients, that we’re constantly improving to make our clinicians lives easier, and our patients lives better. One of the most important ways we do this is with our data, and we work to aggregate it from all our sources to help the team draw brand new insights from it.

Inquire to learn more about our platform technologies.

As Y Combinator's first cannabis start-up, Meadow launched out of the Winter 2015 class. Meadow builds powerful Point of Sale and eCommerce software for retailers in the legal cannabis industry. Meadow’s all-in-one platform allows dispensaries to sell products, manage menus and inventory, reward customers, dispatch delivery and pick-up orders, and create exceptional in-store experiences for customers. Meadow powers dispensaries and delivery services of all sizes, utilizing technology to maintain compliance with local and state regulations, scale with the Adult Use market, and create operational efficiencies that allow these businesses to thrive in a regulated industry. Meadow’s team is dedicated to making the best retail software in cannabis, and to creating a more collaborative and inclusive legal cannabis industry. To learn more about Meadow, visit getmeadow.com.

View Open Roles on careers.patientpoint.com We build amazing, technology enabled solutions that make every doctor-patient engagement better, so patients can live longer, healthier lives. From the top down, we operate within a culture of collaboration and open-minded thinking. We are in it to win it as a team working together, not competing with each other. Your thoughts and ideas are equally valued by leadership and your colleagues. Our employees embody our company values: they’re trustworthy, driven, innovative and welcoming of diversity. You’ll enjoy being part of our group. We’re always learning, and we encourage entrepreneurial thinking. We challenge the status quo and are open to new ideas from every corner of the organization. You can help make a difference in the healthcare industry by discovering groundbreaking solutions that provide value to patients, providers, and sponsors. As a company that is still growing and always evolving, we provide plenty of career and learning potential. In sales, the rewards can be substantial. In tech, you’ll get to advance the industry. In other areas, your goals can be equally ambitious. It’s all within reach, because playing a key part in our success will enhance yours. PatientPoint is the trusted and fully established leader in patient engagement platforms. Our employees are proud to include our name on their resumes. Joining us has definite advantages: stability, rewards and benefits, professional growth potential, plus the knowledge you are in the right place to do your best work.

Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Our dedication to our mission is fueling explosive growth, with both our test volume and revenue doubling year-over-year for the past four years. Our team has grown from 300 employees to more than 1,000 in just two years and we have helped hundreds of thousands of patients get the answers they need. Why medical genetics? Within each of us lies information coded in our DNA that can transform our health. Unlocking those answers to make medicine more personalized requires highly specialized, multidisciplinary collaboration. Our platform is setting the standard for the exploding medical genetics industry by harnessing the power of advanced technologies – robotics, artificial intelligence, machine learning, software engineering – and world-class genetic expertise. We provide genetic information that guides decisions for patients facing a vast array of health questions, from ultra-rare diseases and the most common cancers to starting a family. The team driving our mission thrives in a culture designed to enable innovation at scale. We are grounded in freedom with responsibility and a universal sense of urgency and ownership. Employees are empowered to speak up, try new things and make decisions that push us forward. We provide all employees with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. Each day at Invitae means driving forward toward a new era in which everyone can have their health decisions guided by genetics.

moxieDB is 1st of its kind software application designed specifically for the pharma companies for cross-enterprise collaboration.

Volta Labs was spun out of MIT in 2018 with the simple mission of building biological automation from the ground up. Volta is in the proximity of Kendall Square, known as "the most innovative square mile on the planet". Being part of the open biotech culture in Kendall Square made us realize that today’s biologists are held back by the limitations of existing automation tools. With DNA sequencing in particular, we observed that the advances in DNA readout technologies had moved further along than the advances in the upstream steps of preparing samples for sequencing (sample prep). ‍ What started out as a simple printed circuit board to manipulate colored droplets at the MIT Media Lab during co-founder Udayan Umapathi’s graduate work was quickly directed toward solving the “sample prep bottleneck”. The company raised Seed Funding from top VCs in 2019 and later that year added Will Langford as a co-founder and Head of Engineering. ‍ Since then, we have been heads down in the lab inventing and building novel fluidic and sample manipulation technologies. We take an anti-disciplinary approach to solve very hard problems and weave together instrumentation, fluidics, software, biology and chemistry. While our current focus is on sequencing sample prep, we envision a new approach where a single universal machine automates most biological workflows in genomics, proteomics and synthetic biology.